Yüklüyor......
Extended‐Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent form of heart failure, representing half of the total burden of heart failure. We hypothesised that modulation of the phosphodiesterase type 3/cyclic AMP using a novel oral formulation of milrinone might...
Kaydedildi:
| Yayımlandı: | J Am Heart Assoc |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7670502/ https://ncbi.nlm.nih.gov/pubmed/32552264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015026 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|